药明合联获关联方“输血”超14亿港元,2413万股获认购

财中社
Oct 23, 2025

  10月23日,药明合联(02268)发布公告,关联方药明生物技术已按每股认购股份58.85港元的价格,合计认购2413万股新股份。

  认购事项所得款项净额约为14.14亿港元,每股净价约58.61港元,认购事项前后,公司股权架构如下:

(文章来源:财中社)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10